ArticleSmall (Weinheim an der Bergstrasse, Germany)2026
A Multifunctional Bioactive Nanoscale Coating Deposited by Atmospheric Pressure Plasma Polymerization of Peppermint Essential Oil.
Article in Small (Weinheim an der Bergstrasse, Germany), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Implanted and indwelling medical devices remain challenged by infection, oxidative stress, and chronic inflammation, underscoring the need for multifunctional surface coatings to holistically address these complications. Peppermint essential oil is inherently antibacterial, antioxidant, and anti-inflammatory, yet its integration into stable, contact-active coatings is limited by fabrication constraints. Here, we present a one-step atmospheric pressure plasma polymerisation process that converts peppermint essential oil into a conformal, cross-linked coating that preserves precursor-derived functional groups that drive broad bioactivity. While the coating is substrate-independent, we evaluate its bioactive performance within the context of bladder catheterisation as a pilot application. It scavenges up to 90% of reactive species, reduces pro-inflammatory cytokine expression by up to 60%, and increases anti-inflammatory cytokines by up to 50%, while promoting macrophage polarisation toward an M2 phenotype. The coating exhibits intrinsic antibacterial activity, reducing viable bacteria by 90% (Live/Dead) and 70% (CFUs), attributed to membrane disruption of Gram-negative pathogens. In turn, this interaction potentiates the activity of colistin and levofloxacin, two antibiotics used in catheter-associated urinary tract infection management. Together, these findings establish a stable, multifunctional coating capable of mitigating infection, alleviating inflammation, and enhancing antibiotic performance, while offering a sustainable route for essential-oil-derived biomaterials.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.